Early Intervention with Vedolizumab and Longer-term Surgery Rates in Crohn's Disease: Post Hoc Analysis of the GEMINI Phase 3 and Long-term Safety Programmes
Parambir S. Dulai, Laurent Peyrin-Biroulet, Dirk Demuth, Karen Lasch, Kristen A. Hahn, Dirk Lindner, Haridarshan Patel, Vipul Jairath
Dive into the research topics of 'Early Intervention with Vedolizumab and Longer-term Surgery Rates in Crohn's Disease: Post Hoc Analysis of the GEMINI Phase 3 and Long-term Safety Programmes'. Together they form a unique fingerprint.